KRIYA ONCOLOGY Trademark

Trademark Overview


On Tuesday, January 11, 2022, a trademark application was filed for KRIYA ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the KRIYA ONCOLOGY trademark a serial number of 97213558. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 1, 2024. This trademark is owned by Kriya Therapeutics, Inc.. The KRIYA ONCOLOGY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders
kriya oncology

General Information


Serial Number97213558
Word MarkKRIYA ONCOLOGY
Filing DateTuesday, January 11, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 4, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders
NOT AVAILABLE"ONCOLOGY"
Goods and ServicesTesting, inspection, research, or development of pharmaceutical preparations for gene therapy; research and development in the pharmaceutical and biotechnology fields relating to the treatment of chronic diseases or cancer, namely, metabolic, endocrine, ophthalmic, oncological, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 19, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 19, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKriya Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPalo Alto, CA 94306

Party NameKriya Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRedwood City, CA 94065

Trademark Events


Event DateEvent Description
Friday, January 14, 2022NEW APPLICATION ENTERED
Wednesday, January 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 2, 2022NON-FINAL ACTION E-MAILED
Thursday, July 21, 2022ASSIGNED TO EXAMINER
Tuesday, August 2, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 30, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 30, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 30, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, August 30, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 30, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, September 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 29, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 2, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 2, 2023SOU EXTENSION 1 FILED
Tuesday, May 2, 2023SOU EXTENSION 1 GRANTED
Thursday, May 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED